These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6635110)

  • 21. Monoamines in affective illness. Is there a place for 5HT?
    Eccleston D
    Br J Psychiatry; 1981 Mar; 138():257-8. PubMed ID: 7272620
    [No Abstract]   [Full Text] [Related]  

  • 22. History and evolution of the monoamine hypothesis of depression.
    Hirschfeld RM
    J Clin Psychiatry; 2000; 61 Suppl 6():4-6. PubMed ID: 10775017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Role of postsynaptic noradrenergic receptors in the mechanism of action of antidepressants].
    Cuenca E
    Encephale; 1981; 7(4 Suppl):397. PubMed ID: 7318756
    [No Abstract]   [Full Text] [Related]  

  • 24. Neuropharmacological basis of combining antidepressants.
    de la Gándara J; Rojo JE; Ros S; Agüera L; de Pedro JM
    Acta Psychiatr Scand Suppl; 2005; (428):11-3, 36. PubMed ID: 16307615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Norepinephrine and serotonin axonal dynamics and clinical depression: a commentary on the interaction between serotonergic and noradrenergic axons during axonal regeneration.
    Harley CW
    Exp Neurol; 2003 Nov; 184(1):24-6. PubMed ID: 14637074
    [No Abstract]   [Full Text] [Related]  

  • 26. Serotonin implicated in etiology of seasonal affective disorder.
    O'Rourke DA; Wurtman JJ; Brzezinski A; Nader TA; Chew B
    Psychopharmacol Bull; 1987; 23(3):358-9. PubMed ID: 3324149
    [No Abstract]   [Full Text] [Related]  

  • 27. The therapeutic potential of the endocannabinoid system for the development of a novel class of antidepressants.
    Hill MN; Hillard CJ; Bambico FR; Patel S; Gorzalka BB; Gobbi G
    Trends Pharmacol Sci; 2009 Sep; 30(9):484-93. PubMed ID: 19732971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurotransmitter precursor therapies in affective disorders.
    von Lerber-Good WF
    Int J Vitam Nutr Res Suppl; 1986; 29():69-82. PubMed ID: 2871118
    [No Abstract]   [Full Text] [Related]  

  • 29. The antinociceptive effect of antidepressants--noradrenergic versus serotonergic modes of action?
    Aigner M; Bach M
    Pain; 2000 Nov; 88(2):217. PubMed ID: 11203464
    [No Abstract]   [Full Text] [Related]  

  • 30. Does a true qualitative difference exist in the mode of action of neuroleptics and thymanaleptics on catecholamine neuron systems.
    Moller Nielsen I
    Mod Probl Pharmacopsychiatry; 1970; 5():68-70. PubMed ID: 5527172
    [No Abstract]   [Full Text] [Related]  

  • 31. [Glia as targets for antidepressants: an involvement in glial cell line-derived neurotrophic factor].
    Hisaoka K; Takebayashi M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2007 Nov; 27(5-6):173-9. PubMed ID: 18154038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Noradrenergic challenges in the affective disorders.
    Siever L; Insel T; Uhde T
    J Clin Psychopharmacol; 1981 Jul; 1(4):193-206. PubMed ID: 7028801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Norepinephrine and selective norepinephrine reuptake inhibitors in depression and mood disorders: their pivotal roles.
    Blier P
    J Psychiatry Neurosci; 2001; 26 Suppl(Suppl):S1-2. PubMed ID: 11590963
    [No Abstract]   [Full Text] [Related]  

  • 34. Depression and poor sleep: the effect of monoaminergic antidepressants in a pre-clinical model in rats.
    Sánchez C; Brennum LT; Stórustovu Sí; Kreilgård M; Mørk A
    Pharmacol Biochem Behav; 2007 Mar; 86(3):468-76. PubMed ID: 17303232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Mechanism of action of antidepressants and therapeutic perspectives].
    Bourin M; David DJ; Jolliet P; Gardier A
    Therapie; 2002; 57(4):385-96. PubMed ID: 12422559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Basic psychopharmacology of antidepressants, part 2: Estrogen as an adjunct to antidepressant treatment.
    Stahl SM
    J Clin Psychiatry; 1998; 59 Suppl 4():15-24. PubMed ID: 9554317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of duloxetine, an antidepressant drug candidate, on concentrations of monoamines and their metabolites in rats and mice.
    Fuller RW; Hemrick-Luecke SK; Snoddy HD
    J Pharmacol Exp Ther; 1994 Apr; 269(1):132-6. PubMed ID: 7513356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antidepressant and antipsychotic agents.
    Lahti RA
    Naturwissenschaften; 1979 Aug; 66(8):403-9. PubMed ID: 41188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The effect of antidepressants on catecholamine metabolism in depressive patients].
    Usherenko LS
    Fiziol Zh; 1973; 19(2):205-10. PubMed ID: 4704977
    [No Abstract]   [Full Text] [Related]  

  • 40. Noradrenergic and serotonergic abnormalities in depression: stress-induced dysfunction?
    Dinan TG
    J Clin Psychiatry; 1996; 57 Suppl 4():14-8. PubMed ID: 8636061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.